![](/img/cover-not-exists.png)
Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention
Edouard Cheneau, Daniel Canos, Pramod K. Kuchulakanti, Seung-Woon Rha, Lowell F. Satler, William O. Suddath, Kenneth M. Kent, Augusto D. Pichard, Ron WaksmanVolume:
94
Year:
2004
Language:
english
Pages:
4
DOI:
10.1016/j.amjcard.2004.05.068
File:
PDF, 97 KB
english, 2004